文献速递脑血管病神经重症与神经感染

镁水平与脑室外引流置管出血并发症风险

Magnesium and Risk of Bleeding Complications From Ventriculostomy Insertion.
PubMed 文献 · Stroke · 2020-08-10

本前瞻性观察研究纳入自发性脑出血和动脉瘤性蛛网膜下腔出血患者,评估EVD置管时血镁水平与导管道出血(CTH)的关系。327例EVD操作中发生50例CTH(15.3%),CTH患者血镁中位数低于无CTH者(1.8 vs 2.0 mg/dL,P<0.0001),校正后血镁每升高0.1 mg/dL,CTH风险降低(OR 0.67,95%CI 0.56-0.78)。

要点

  • EVD置管时血镁较低是出血并发症的独立预测因素。
  • 术前血镁升高与CTH风险降低相关,提示治疗机会。
  • 脑出血与蛛网膜下膜下腔出血亚组中效应相似。

核心结论

  • EVD置管时血镁较低是出血并发症的独立预测因素,术前提高血镁可能降低出血风险。

研究设计与样本

  • 前瞻性观察研究,纳入自发性脑出血和动脉瘤性蛛网膜下腔出血患者,共分析327例EVD操作。

主要发现

  • 327例EVD操作中发生50例CTH(15.3%),脑出血组21/116(18.1%),蛛网膜下腔出血组29/211(13.7%)。
  • CTH患者血镁中位数低于无CTH者(1.8 vs 2.0 mg/dL,P<0.0001)。
  • 校正其他危险因素后,血镁每升高0.1 mg/dL,CTH风险降低(OR 0.67,95%CI 0.56-0.78,P<0.0001),脑出血和蛛网膜下腔出血亚组效应相似。
  • 校正初始镁和其他危险因素后,术前血镁升高(OR 0.68,95%CI 0.52-0.85)和术前硫酸镁剂量(OR 0.67,95%CI 0.40-0.97)与CTH风险降低相关。

临床怎么用

  • EVD置管前可关注血镁水平,低镁可能提示出血并发症风险较高。
  • 术前适当补充镁可能降低EVD置管后出血风险,但需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Hemorrhages are a serious complication of brain surgery, and magnesium has shown hemostatic properties in hemorrhagic stroke and non-neurological surgeries. External ventricular drain (EVD) insertion is an advantageous model of emergency neurosurgical hemorrhage risk because it is common, standardized, and the operator is blinded to the outcome during the procedure. We tested the hypothesis that low magnesium is associated with risk of hemorrhagic complications from EVD insertion. METHODS: Patients with spontaneous intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage were enrolled in a prospective, observational study. Demographic and clinical variables were prospectively recorded, including serum magnesium measurements. Catheter tract hemorrhage (CTH) was measured on postoperative head computed tomography within 48 hours of EVD insertion. RESULTS: We observed 50 CTH among 327 EVD procedures (15.3%) distributed similarly among intracerebral hemorrhage (21/116 [18.1%]) and subarachnoid hemorrhage (29/211 [13.7%]). Magnesium was lower in patients with CTH compared with those without (median 1.8 versus 2.0 mg/dL, P<0.0001). Higher magnesium was associated with lower odds of CTH (odds ratio 0.67 per 0.1 mg/dL magnesium [95% CI, 0.56-0.78], P<0.0001) after adjustment for other risk factors, with similar effect in the intracerebral hemorrhage and subarachnoid hemorrhage subgroups. Preprocedural increase in magnesium (odds ratio 0.68 [0.52-0.85]) and dose of preprocedural magnesium sulfate (odds ratio 0.67 [0.40-0.97]) were associated with reduced CTH risk after adjustment for initial magnesium and other risk factors. CONCLUSIONS: Lower magnesium at the time of EVD insertion was an independent predictor of hemorrhagic complications. Baseline risk was attenuated by preprocedural increases in magnesium, suggesting a therapeutic opportunity.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Maas MB, Jahromi BS, Batra A, et al. Magnesium and Risk of Bleeding Complications From Ventriculostomy Insertion. Stroke. 2020. PMID: 32772685. doi:10.1161/STROKEAHA.120.030128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。